CN102166352A - 猪流感二价灭活疫苗的制备方法及其产品 - Google Patents
猪流感二价灭活疫苗的制备方法及其产品 Download PDFInfo
- Publication number
- CN102166352A CN102166352A CN2011100919351A CN201110091935A CN102166352A CN 102166352 A CN102166352 A CN 102166352A CN 2011100919351 A CN2011100919351 A CN 2011100919351A CN 201110091935 A CN201110091935 A CN 201110091935A CN 102166352 A CN102166352 A CN 102166352A
- Authority
- CN
- China
- Prior art keywords
- swine flue
- cell
- swine
- subtype virus
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940031551 inactivated vaccine Drugs 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 206010069767 H1N1 influenza Diseases 0.000 title abstract 7
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 title abstract 7
- 201000010740 swine influenza Diseases 0.000 title abstract 7
- 239000000427 antigen Substances 0.000 claims abstract description 35
- 108091007433 antigens Proteins 0.000 claims abstract description 35
- 102000036639 antigens Human genes 0.000 claims abstract description 35
- 239000002671 adjuvant Substances 0.000 claims abstract description 10
- 210000003837 chick embryo Anatomy 0.000 claims abstract description 5
- 230000002265 prevention Effects 0.000 claims abstract description 3
- 241000282898 Sus scrofa Species 0.000 claims description 105
- 210000004027 cell Anatomy 0.000 claims description 68
- 241000197306 H1N1 subtype Species 0.000 claims description 49
- 241000252870 H3N2 subtype Species 0.000 claims description 47
- 239000007788 liquid Substances 0.000 claims description 32
- 241000700605 Viruses Species 0.000 claims description 29
- 241000287828 Gallus gallus Species 0.000 claims description 25
- 231100000614 poison Toxicity 0.000 claims description 24
- 239000002574 poison Substances 0.000 claims description 22
- 210000001161 mammalian embryo Anatomy 0.000 claims description 21
- 229960005486 vaccine Drugs 0.000 claims description 18
- 230000000890 antigenic effect Effects 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 238000011218 seed culture Methods 0.000 claims description 14
- 238000004113 cell culture Methods 0.000 claims description 10
- 230000009849 deactivation Effects 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 10
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- 229940055695 pancreatin Drugs 0.000 claims description 9
- 239000000568 immunological adjuvant Substances 0.000 claims description 8
- 230000000937 inactivator Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 7
- 108010019160 Pancreatin Proteins 0.000 claims description 7
- 239000002609 medium Substances 0.000 claims description 7
- 210000003501 vero cell Anatomy 0.000 claims description 7
- 230000000813 microbial effect Effects 0.000 claims description 6
- 238000006386 neutralization reaction Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 5
- -1 divinyl imines Chemical class 0.000 claims description 4
- 239000002054 inoculum Substances 0.000 claims description 4
- 238000005096 rolling process Methods 0.000 claims description 4
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 4
- 238000012423 maintenance Methods 0.000 claims description 3
- 238000004114 suspension culture Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims 1
- 241000725681 Swine influenza virus Species 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 abstract description 12
- 210000002966 serum Anatomy 0.000 abstract description 6
- 241000282887 Suidae Species 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 description 8
- 210000003097 mucus Anatomy 0.000 description 7
- 241000712461 unidentified influenza virus Species 0.000 description 7
- 230000001779 embryotoxic effect Effects 0.000 description 6
- 231100000238 embryotoxicity Toxicity 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000002435 venom Substances 0.000 description 6
- 210000001048 venom Anatomy 0.000 description 6
- 231100000611 venom Toxicity 0.000 description 6
- 235000015278 beef Nutrition 0.000 description 5
- 238000007596 consolidation process Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000035931 haemagglutination Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 4
- 210000000621 bronchi Anatomy 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 241000204031 Mycoplasma Species 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 239000000273 veterinary drug Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 101150039660 HA gene Proteins 0.000 description 2
- 101150080862 NA gene Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000004894 snout Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000005723 virus inoculator Substances 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000012353 Contagious Pleuropneumonia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102100038353 Gremlin-2 Human genes 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 101001032860 Mus musculus Gremlin-2 Proteins 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
Images
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
序列名称 | 上游引物序列(5′-3′) | 下游引物序列(5′-3′) |
H1 | H1-F-AGCAAAAGCAGGGGATAATCAA | H1-R-ACAAGGGTGTTTTTCCAT |
N1 | N1-F-CTACTTGTCAATGGTGAATG | N1-R-TGAATCCAAATCAAAAGATAAT |
H3 | H3-F-AGCAAAAGCAGGGGATAC | H3-R-ACAAGGGTGTTTTTAATCAT |
N2 | N2-FGCAAAAGCAGGAGTGAAAAGATGAA | N2-R-ACAACTTGAGCTGGACCATGCTA |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110091935 CN102166352B (zh) | 2011-04-13 | 2011-04-13 | 猪流感二价灭活疫苗的制备方法及其产品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110091935 CN102166352B (zh) | 2011-04-13 | 2011-04-13 | 猪流感二价灭活疫苗的制备方法及其产品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102166352A true CN102166352A (zh) | 2011-08-31 |
CN102166352B CN102166352B (zh) | 2013-01-23 |
Family
ID=44487794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110091935 Active CN102166352B (zh) | 2011-04-13 | 2011-04-13 | 猪流感二价灭活疫苗的制备方法及其产品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102166352B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103468647A (zh) * | 2013-09-03 | 2013-12-25 | 华中农业大学 | 猪流感h1n1和h3n2亚型的二价灭活疫苗 |
CN103667196A (zh) * | 2012-09-25 | 2014-03-26 | 普莱柯生物工程股份有限公司 | 含有猪圆环病毒2型抗原与猪流感抗原的疫苗组合物 |
CN104162154A (zh) * | 2013-05-17 | 2014-11-26 | 华威特(北京)生物科技有限公司 | 牛病毒性腹泻、牛传染性鼻气管炎二价灭活疫苗及其制备方法和应用 |
CN107250353A (zh) * | 2015-02-26 | 2017-10-13 | 勃林格殷格翰动物保健有限公司 | 二价猪流感病毒疫苗 |
CN107375918A (zh) * | 2016-05-16 | 2017-11-24 | 中国农业科学院上海兽医研究所 | 重组h1n1亚型猪流感二价灭活疫苗及其制备方法和应用 |
CN108130315A (zh) * | 2017-12-20 | 2018-06-08 | 哈药集团生物疫苗有限公司 | H3n2亚型猪流感病毒细胞适应株及其制备的灭活疫苗和应用 |
-
2011
- 2011-04-13 CN CN 201110091935 patent/CN102166352B/zh active Active
Non-Patent Citations (3)
Title |
---|
夏艳锋等: "猪流感病毒H3N2/H1N1二价灭活疫苗", 《兽医市场指南》 * |
李映波等: "二乙烯亚胺灭活流感病毒的效果观察", 《中国生物制品学杂志》 * |
王家福等: "猪流感(H1N1 H3N2亚型)二价灭活疫苗试制报告", 《中国兽医杂志》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103667196A (zh) * | 2012-09-25 | 2014-03-26 | 普莱柯生物工程股份有限公司 | 含有猪圆环病毒2型抗原与猪流感抗原的疫苗组合物 |
CN103667196B (zh) * | 2012-09-25 | 2016-06-08 | 普莱柯生物工程股份有限公司 | 含有猪圆环病毒2型抗原与猪流感抗原的疫苗组合物 |
CN104162154A (zh) * | 2013-05-17 | 2014-11-26 | 华威特(北京)生物科技有限公司 | 牛病毒性腹泻、牛传染性鼻气管炎二价灭活疫苗及其制备方法和应用 |
CN104162154B (zh) * | 2013-05-17 | 2017-02-08 | 华威特(江苏)生物制药有限公司 | 牛病毒性腹泻、牛传染性鼻气管炎二联灭活疫苗及其制备方法和应用 |
CN103468647A (zh) * | 2013-09-03 | 2013-12-25 | 华中农业大学 | 猪流感h1n1和h3n2亚型的二价灭活疫苗 |
CN103468647B (zh) * | 2013-09-03 | 2015-04-22 | 华中农业大学 | 猪流感h1n1和h3n2亚型的二价灭活疫苗 |
CN107250353A (zh) * | 2015-02-26 | 2017-10-13 | 勃林格殷格翰动物保健有限公司 | 二价猪流感病毒疫苗 |
US10905756B2 (en) | 2015-02-26 | 2021-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Bivalent swine influenza virus vaccine |
CN107250353B (zh) * | 2015-02-26 | 2021-07-23 | 勃林格殷格翰动物保健有限公司 | 二价猪流感病毒疫苗 |
CN107375918A (zh) * | 2016-05-16 | 2017-11-24 | 中国农业科学院上海兽医研究所 | 重组h1n1亚型猪流感二价灭活疫苗及其制备方法和应用 |
CN108130315A (zh) * | 2017-12-20 | 2018-06-08 | 哈药集团生物疫苗有限公司 | H3n2亚型猪流感病毒细胞适应株及其制备的灭活疫苗和应用 |
CN108130315B (zh) * | 2017-12-20 | 2021-08-13 | 哈药集团生物疫苗有限公司 | H3n2亚型猪流感病毒细胞适应株及其制备的灭活疫苗和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102166352B (zh) | 2013-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Friedewald et al. | Low-temperature-grown RS virus in adult volunteers | |
CN102166352B (zh) | 猪流感二价灭活疫苗的制备方法及其产品 | |
CN111632137B (zh) | 猫杯状病毒病、猫传染性鼻气管炎和猫泛白细胞减少症三联疫苗及其制备方法和应用 | |
CN104162154B (zh) | 牛病毒性腹泻、牛传染性鼻气管炎二联灭活疫苗及其制备方法和应用 | |
CN106729692B (zh) | 牛病毒性腹泻、牛传染性鼻气管炎、牛副流感三联灭活疫苗及其制备方法 | |
Kumagai et al. | Phylogenetic and antigenic analysis of bovine parainfluenza virus type 3 isolated in Japan between 2002 and 2019 | |
CN102727884B (zh) | 猪繁殖与呼吸综合征、伪狂犬病二联活疫苗及其制备方法 | |
CN104338127A (zh) | 一种h9n2亚型禽流感灭活疫苗的生产方法及其制品 | |
CN107823639B (zh) | 牛病毒性腹泻病毒灭活疫苗及其制备方法 | |
CN102727883B (zh) | 猪繁殖与呼吸综合征与猪瘟二联疫苗及其用途 | |
CN103923885B (zh) | 鸡传染性法氏囊病毒Vero细胞适应株及其应用 | |
CN102443571B (zh) | 一株鸡源h9n2禽流感病毒毒株及其应用 | |
CN103937753B (zh) | H9n2亚型禽流感病毒毒株及其灭活疫苗和应用 | |
CN103937817B (zh) | 鸡新城疫病毒yt毒株、其全基因组序列及其应用 | |
CN103275939A (zh) | 适于细胞培养的嵌合ibv h120 s1基因膜外区的重组病毒及其构建方法和应用 | |
CN105400745A (zh) | 一种猪繁殖与呼吸综合征病毒基因工程毒株及其灭活疫苗和疫苗制备方法 | |
CN110124027B (zh) | 一种牛轮状病毒、牛冠状病毒二联灭活疫苗及其制备方法 | |
CN111729091A (zh) | 一种用家兔检验猪塞内卡病毒病灭活疫苗效力的方法 | |
CN104073470A (zh) | 一种h9n2亚型禽流感病毒的转瓶培养方法 | |
CN103468647A (zh) | 猪流感h1n1和h3n2亚型的二价灭活疫苗 | |
CN110302374A (zh) | 犬用疫苗及其制备方法和应用 | |
CN102805862A (zh) | 一种vero细胞培养新布尼亚病毒纯化灭活疫苗的制备方法 | |
CN106929480A (zh) | 猪繁殖与呼吸综合征病毒株及其应用 | |
CN102727882B (zh) | 猪繁殖与呼吸综合征、猪瘟、伪狂犬病的三联活疫苗及其制备方法 | |
CN105727275B (zh) | 一种鸭肝炎二价活疫苗及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 100085 B302 room, three floor, B District, 5 Haidian District Road, Beijing, China Applicant after: SINOVET (BEIJING) BIOTECHNOLOGY Co.,Ltd. Address before: 100085 B302 room, three floor, B District, 5 Haidian District Road, Beijing, China Applicant before: BEIJING HUAWEITE BIOTECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: VITAL CHINA TECHNOLOGY CO., LTD. TO: HUAWEITE (BEIJING) BIOTECHNOLOGY CO., LTD. |
|
ASS | Succession or assignment of patent right |
Owner name: SINOVET (JIANGSU) BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SINOVET (BEIJING) BIOTECHNOLOGY CO., LTD. Effective date: 20120507 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100085 HAIDIAN, BEIJING TO: 225300 TAIZHOU, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120507 Address after: Xinshengyuan 1 Building No. 225300 Jiangsu city of Taizhou Province medicine City Avenue room 1002 Applicant after: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Address before: 100085 B302 room, three floor, B District, 5 Haidian District Road, Beijing, China Applicant before: SINOVET (BEIJING) BIOTECHNOLOGY Co.,Ltd. |
|
CI01 | Publication of corrected invention patent application |
Correction item: Applicant Correct: SINOVET (BEIJING) BIOTECHNOLOGY Co.,Ltd.|100085, Haidian District, Beijing Road, No. 5, B District, room three, B302|Sinovet (Jiangsu) Biological Pharmaceutical Co., Ltd. False: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd.|Xinshengyuan 1 Building No. 225300 Jiangsu city of Taizhou Province medicine City Avenue room 1002 Number: 35 Volume: 27 |
|
ERR | Gazette correction |
Free format text: CORRECT: APPLICANT; FROM: SINOVET (JIANGSU) BIOPHARMACEUTICAL CO., LTD.:225300 TAIZHOU, JIANGSU PROVINCE TO: SINOVET (BEIJING) BIOTECHNOLOGY CO., LTD.:100085 HAIDIAN, BEIJING; SINOVET (JIANGSU) BIOPHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170901 Address after: Xinshengyuan 1 Building No. 225300 Jiangsu city of Taizhou Province medicine City Avenue room 1002 Patentee after: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Address before: 100085 B302 room, three floor, B District, 5 Haidian District Road, Beijing, China Co-patentee before: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Patentee before: SINOVET (BEIJING) BIOTECHNOLOGY Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 225300 Jiang Gao Avenue, Taizhou, Jiangsu Province, No. 409 Patentee after: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Address before: 225300 room 1002, source building, 1 drug Road, Taizhou, Jiangsu. Patentee before: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method and products of bivalent inactivated swine influenza vaccine Effective date of registration: 20221008 Granted publication date: 20130123 Pledgee: Zhejiang Commercial Bank Co.,Ltd. Taizhou Branch Pledgor: SINOVET (JIANGSU) BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980017467 |